Trials / Unknown
UnknownNCT04063345
Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
A Prospective, Open Label, Multicenter and Randomized Study of Clinical Outcomes of Intravascular Ultrasound -Guided and Angiography-Guided Primary Percutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To examine the impact of IVUS guidance on clinical outcomes in the patient with Acute ST Segment Elevated Myocardial Infarction.
Detailed description
Intravascular ultrasound (IVUS) has been increasingly used as a guide for percutaneous coronary intervention (PCI) during elective as well as emergent clinical scenario. Recent small number randomized studies, large scale registries as well as meta-analysis have consistently demonstrated advantages of IVUS-guidance over angiography-guide alone with respect to the lower incident of death, myocardial infarction and target vessel revascularization. There are sparse data available on the clinical impact of IVUS-guided PCI in the setting of acute myocardial infarction (AMI) and its use remains a matter of controversy as shown by previous studies. This study is to examine the impact of IVUS guidance on clinical outcomes in the patient with Acute ST Segment Elevated Myocardial Infarction (STEMI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | IVUS-guided PCI | Performing intravascular ultrasound before or/and after percutaneous intervention |
| PROCEDURE | Angiography-guided PCI | Performing percutaneous intervention without intravascular ultrasound guidance |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-10-01
- Completion
- 2023-10-01
- First posted
- 2019-08-21
- Last updated
- 2021-01-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04063345. Inclusion in this directory is not an endorsement.